MedCity News

A 3D medical illustration of vascular constriction with white arrows indicating reduced and impeded blood flow. 3d rendering medical illustrastion.

This Ear-Based Device Could Save Patients from Brain Bleed Complications

Doctor at work. Medical professional using tablet in clinic office. Medicine and health care concept.

Color Broadens Cancer Expert Medical Opinion Program

Color expanded its Expert Medical Opinion program with a new peer-to-peer service that connects oncologists with cancer specialists.

By Marissa Plescia

BioPharma, Pharma

With New Phase 3 Data, Roche Claims an Edge Over Amgen and BMS Lung Cancer Drugs

Roche’s divarasib was designed offer greater potency and selectivity to KRAS G12C compared to first-generation drugs in this class marketed by Amgen and Bristol Myers Squibb. The Swiss pharma company now plans to submit the data to regulators for review as a potential treatment for non-small cell lung cancer driven by this particular mutated protein.

By Frank Vinluan

Latest Video

Latest News

Payers

Debunked Episode 28: A Little More Transparency, A Little More Action

Debunked Podcast co-hosts Arundhati Parmar and Samir Batra discussed some of the takeaways from UnitedHealth Group’s press event, transparency, and pharma company Lilly’s efforts to hold hospitals accountable in the 340B drug discount program.

By Stephanie Baum

MedCity Influencers

Hospital Networks are Becoming Targets in Cyberwarfare, and They’re Unequipped to Deal With It

The question facing hospital cybersecurity leaders today is no longer whether they will be collateral damage in a broader war; it’s how to reckon with adversaries who will target healthcare for ideological or political reasons — hackers may not have any particular interest in quick resolutions.

By Errol Weiss

Opinion

Why the Office of Personnel Management Needs Access to Government Employee Health Plan Claims Data

Without knowledge of the exact amount providers billed and middlemen charged in fees, OPM can’t fix payment discrepancies.

By Cynthia A. Fisher

MedCity Influencers

Hantavirus Is the Warning Signal America Should Not Ignore

Are we genuinely building long-term preparedness infrastructure, or are we repeatedly improvising our way from one outbreak cycle to the next?

By David A. Dodd

MedCity Influencers

Artificial intelligence helps doctors analyze medical data for accurate treatment, store and analyze patient data.

What Happens When AI Stops Answering and Starts Handling Healthcare Tasks?

Patients are trying to navigate insurance confusion, coordinate care, manage prescriptions, and understand the following steps that often feel unclear. Static chatbots were never built for this level of responsibility. Agentic AI is. Or at least that is the idea.

By Jahnavi Kachhia

Health Tech, Startups, Devices & Diagnostics

Young adult woman soldier getting professional help for stress related problems. She is suffering from post traumatic stress disorder

FDA Clears First Neurostimulation Device for PTSD

Neurovalens' Modius Spero has become the first FDA-approved neuromodulation device for treating PTSD symptoms. Veterans are set to gain access through the VA this summer.

By Katie Adams

BioPharma, Pharma

Orca Bio Cell Therapy Gets Landmark FDA Nod for New Kind of Living Medicine

FDA approval of Orca Bio’s Tregzi makes it the first cell therapy based on regulatory T cells, or Tregs. Clinical trial results showed reduced risk of graft-versus-host disease, a common complication of the allogeneic stem cell transplants that are a standard treatment for certain blood cancers.

By Frank Vinluan

Health Tech

A human hand interacts with an artificial intelligence robotic hand with medical icons and a digital interface on dark background, illustrating healthcare technology AI trust

Evernorth Invests $100M for AI Specialty Pharmacy Program

Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care.

By Marissa Plescia

Health Tech

MedCity FemFwd: Inside Winona’s New Women’s Health Research Initiative

In this episode, we’re joined by Dr. Cathleen Brown, medical director of menopause company Winona. We discuss the company’s new Winona Research Initiative, which seeks to fund and support menopause and women's health research.

By Marissa Plescia

MedCity Influencers

Your Healthcare AI Strategy Is Probably an Architecture Problem

These three patterns keep showing up, and each is much cheaper to prevent than to fix later.

By Vallikranth Ayyagari

MedCity Influencers

Healthcare Retention Depends On Better Pathways, Not Just Better Pay

When workers feel stuck in place, with limited opportunities to advance or deepen their skills, disengagement tends to follow. In allied health roles, where burnout is already high and many touch the patient experience, it is a risk healthcare employers cannot afford to ignore.

By Angie Holub

MedCity Influencers

What Healthcare Leaders Should Know Before Implementing AI-Powered Documentation Tools

These tools are worth implementing. They are not worth implementing without the right preparation.

By Giriraj Tosh Purohit

Artificial Intelligence, BioPharma, Health Tech

Anthropic Launches Claude Science to Court Pharma Ahead of IPO

Anthropic unveiled Claude Science, an AI workbench designed to run — not just assist with — pharma research. The company is seeking to build out its customer base in the pharma sector as it deepens its healthcare push ahead of a widely anticipated IPO.

By Katie Adams

BioPharma, Pharma

Servier Executive: ‘We Are Not Looking for Blockbusters, We’re Looking for Innovative Science’

Servier completed its acquisition of Day One Biopharmaceuticals and its buyout of Edgewise Therapeutics’ neuromuscular business is expected to close later this year. At the BIO International Convention, Servier’s top business development executive explained the rationale for these deals and how they fit the company’s overall strategy.

By Frank Vinluan

Payers, Health Tech

Zelis Unveils Solution to Tackle Payer IDR Challenges

Zelis has introduced an AI solution to help health insurers streamline the No Surprises Act's Independent Dispute Resolution process.

By Marissa Plescia